Patient information
| Patient | Age (Years)/Sex | Pathology | Tumor Resection Volume (mL) | WBNAA mmol/L | MD (mm2s−1) | Clinical Follow-up: Status, Time Elapsed Since Surgery |
|---|---|---|---|---|---|---|
| 1 | 55/M | Anaplastic Mixed GGNC (III) | 45 | 8.4 | 1.068 | Deceased, 6 months |
| 2 | 49/F | GBM (IV) | 59 | 9.5 | .940 | Deceased, 12 months |
| 3 | 35/M | GBM (IV) | 99 | 10.7 | .923 | Deceased, 12 months |
| 4 | 37/M | Mixed GN (II) | N/A | 8.6 | .953 | Stable, 17 months |
| 5 | 30/M | Mixed GN (II) | 9 | 9.2 | .982 | Stable, 15 months |
| 6 | 23/F | GGNC-DNT (I) | 32 | 12.6 | .894 | Stable, 10 months |
| 7 | 39/F | Mixed GN (II) | 37 | 12.2 | .917 | Stable, 12 months |
| 8 | 74/M | GBM (IV) | 75 | 7.8 | 1.065 | Deceased, 9 months |
| 9 | 62/M | Anaplastic GGNC (III) | 41 | 7.9 | 1.009 | Stable, 10 months |
| 10 | 32/F | Mixed GGNC (II) | N/A | 9.8 | .872 | Stable, 12 months |
Note:—WBNAA indicates whole-brain N-acetylaspartate; MD, mean diffusivity; GGNC, ganglioglioneurocytoma; DNT, dysembryoplastic neuroepithelial tumor; GN, glioneurocytoma; DFA, diffuse fibrillary astrocytoma; GBM, glioblastoma multiforme; N/A, below our measurement sensitivity of 9 cm3.